248 related articles for article (PubMed ID: 23934191)
21. Involvement of LIMK1/2 in actin assembly during mouse embryo development.
Duan X; Zhang HL; Wu LL; Liu MY; Pan MH; Ou XH; Sun SC
Cell Cycle; 2018; 17(11):1381-1389. PubMed ID: 29943641
[TBL] [Abstract][Full Text] [Related]
22. Structural Aspects of LIMK Regulation and Pharmacology.
Chatterjee D; Preuss F; Dederer V; Knapp S; Mathea S
Cells; 2022 Jan; 11(1):. PubMed ID: 35011704
[TBL] [Abstract][Full Text] [Related]
23. Lim kinases, regulators of actin dynamics.
Bernard O
Int J Biochem Cell Biol; 2007; 39(6):1071-6. PubMed ID: 17188549
[TBL] [Abstract][Full Text] [Related]
24. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.
Nagel A; Huegel J; Petrilli A; Rosario R; Victoria B; Hardin HM; Fernandez-Valle C
Oncogene; 2024 Mar; 43(13):921-930. PubMed ID: 38336988
[TBL] [Abstract][Full Text] [Related]
26. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
[TBL] [Abstract][Full Text] [Related]
27. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
[TBL] [Abstract][Full Text] [Related]
28. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.
Yu Q; Gratzke C; Wang Y; Herlemann A; Sterr CM; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Stief CG; Hennenberg M
Br J Pharmacol; 2018 Jun; 175(11):2077-2096. PubMed ID: 29574791
[TBL] [Abstract][Full Text] [Related]
30. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
[TBL] [Abstract][Full Text] [Related]
31. LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs.
Po'uha ST; Shum MS; Goebel A; Bernard O; Kavallaris M
Oncogene; 2010 Jan; 29(4):597-607. PubMed ID: 19881550
[TBL] [Abstract][Full Text] [Related]
32. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation.
Mardilovich K; Gabrielsen M; McGarry L; Orange C; Patel R; Shanks E; Edwards J; Olson MF
Mol Cancer Ther; 2015 Jan; 14(1):246-58. PubMed ID: 25344584
[TBL] [Abstract][Full Text] [Related]
33. mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.
Giovannini M; Bonne NX; Vitte J; Chareyre F; Tanaka K; Adams R; Fisher LM; Valeyrie-Allanore L; Wolkenstein P; Goutagny S; Kalamarides M
Neuro Oncol; 2014 Apr; 16(4):493-504. PubMed ID: 24414536
[TBL] [Abstract][Full Text] [Related]
34. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.
Kim S; Jho EH
BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717
[TBL] [Abstract][Full Text] [Related]
35. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators.
Manetti F
Med Res Rev; 2012 Sep; 32(5):968-98. PubMed ID: 22886629
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.
Mandati V; Del Maestro L; Dingli F; Lombard B; Loew D; Molinie N; Romero S; Bouvard D; Louvard D; Gautreau AM; Pasmant E; Lallemand D
J Biol Chem; 2019 Aug; 294(35):12992-13005. PubMed ID: 31296571
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease.
Heredia L; Helguera P; de Olmos S; Kedikian G; Solá Vigo F; LaFerla F; Staufenbiel M; de Olmos J; Busciglio J; Cáceres A; Lorenzo A
J Neurosci; 2006 Jun; 26(24):6533-42. PubMed ID: 16775141
[TBL] [Abstract][Full Text] [Related]
38. LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.
Aggelou H; Chadla P; Nikou S; Karteri S; Maroulis I; Kalofonos HP; Papadaki H; Bravou V
Virchows Arch; 2018 May; 472(5):727-737. PubMed ID: 29352327
[TBL] [Abstract][Full Text] [Related]
39. Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2.
Sumi T; Matsumoto K; Takai Y; Nakamura T
J Cell Biol; 1999 Dec; 147(7):1519-32. PubMed ID: 10613909
[TBL] [Abstract][Full Text] [Related]
40. LIM kinase and slingshot are critical for neurite extension.
Endo M; Ohashi K; Mizuno K
J Biol Chem; 2007 May; 282(18):13692-702. PubMed ID: 17360713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
